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Abstract: 
 
Objective: To determine the etiology of hyponatremia in patients admitted to 
GRH and correlation with serum cortisol levels. 
Study Design: Observational study involving 50 in patients who have serum 
sodium levels less than 130 meq/L for a period of 1 year. 
Results: Mean age of the patients - 52.5 years. 18% had severe hyponatremia. 
48% of males had raised cortisol values as against 17% of females. Only 34% 
of patients had raised cortisol values. Hypervolemia was seen in 46%, 
Euvolemia in 32%, hypovolemia in 22%, 78% of patients showed hypo 
osmolality. Mean serum sodium values were found to be 123meq/L. 
Conclusion: Chronic kidney disease, Respiratory causes, fever and acute 
gastroenteritis were the most common etiologies. Cortisol levels were not found 
to be significantly elevated in patients with hyponatremia. 
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INTRODUCTION 
 
 Hyponatremia is the most common electrolyte disorder among 
hospitalized patients26 and has been associated with increased mortality 
ranging from 5% to 50%, depending on severity and acuity of onset. Its 
prevalence among non-hospitalized elderly patients has been estimated to 
be between 7-11.4%, increasing to 11-22.5% among hospitalized patients.26 
 A study done by Kende M et al in over 30,000 patients over two 
years observed that hyponatremia was higher among medical and pediatric 
patients. Various studies have indicated that elderly patients showed a 
higher predisposition to develop hyponatremia. Natkunam et al observed 
that majority of patients developed hyponatremia during their hospital stay. 
Various studies have emphasized the susceptibilities of hospitalized elderly 
patients to hyponatremia. 
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REVIEW OF LITERATURE 
 
Sodium and Water   
 
 Water is the most abundant constituent in the body, accounting for 
50% of body weight in women and 60% in men. Total body water is 
distributed in two major compartments: 55-75% is intracellular 
[intracellular fluid (ICF)], and 25-45% is extracellular fluid (ECF)]. ECF is 
subdivided into intravascular plasma water and extra vascular (interstitial) 
spaces in a ratio of 3:1. Fluid movement between the intravascular and 
interstitial spaces occurs across the capillary wall and is determined by 
Starling forces, i.e., capillary hydraulic pressure and colloid osmotic 
pressure. The transcapillary hydraulic pressure gradient creeds the 
corresponding oncotic pressure gradient, thus favoring the movement of 
plasma ultrafiltrate into the extravascular space. The return of fluid into the 
intravascular compartment occurs via lymphatic flow. 
 
 The solute or particle concentration of a fluid is known as its 
osmolality and is expressed as milliosmoles per kilogram of water 
(mosmol/kg). Water easily diffuses across most cell membranes to achieve 
osmotic equilibrium (ECF osmolality = ICF osmolality). Notably, the 
extracellular and intracellular solute compositions differ considerably 
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owing to the activity of various transporters, channels, and ATP-driven 
membrane pumps. The major ECF components are Na+ and its 
accompanying anions CI- and HC03-, whereas K' and organic phosphate 
esters (ATP, creatine phosphate, and phospholipids) are the  predominant 
ICF osmoles. Solutes that are restricted to the ECF or the ICF determine the 
tonicity or effective osmolality of that compartment. Certain solutes, 
particularly urea, do not contribute to water shifts across most membranes 
and are thus known as ineffective osmoles. 
Water Balance  
 Vasopressin secretion, water ingestion, and renal water transport 
collaborate to maintain human body fluid osmolality between 280 and 295 
mosmol/kg. Vasopressin (AVP) is synthesized in magno-cellular neurons 
within the hypothalamus; the distal axons of those neurons project to the 
posterior pituitary or neurohypophysis, from which AVP is released into the 
circulation. A network of central osmoreceptor neurons that includes the 
AVP-expressing magnocelllular neurons themselves sense circulating 
osmolality via nonselective, stretch-activated cation channels. These 
osmoreceptor neurons are activated or inhibited by modest increases and 
decreases in circulating osmolality, respectively; activation leads to AVP 
release and thirst. 
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AVP secretion is stimulated as systemic osmolality increases above a 
threshold level of -285 mosmol/kg, above which there is a linear 
relationship between osmolality and circulating AVP. Thirst and thus water 
ingestion also are activated at 285 mosmol/kg, beyond which there is an 
equivalent linear increase in the perceived intensity of thirst as a function of 
circuiting osmolality. Changes in blood volume and blood pressure are also 
direct stimuli for AVP release and thirst, albeit with a less sensitive 
response profile. Of perhaps greater clinical relevance to the 
pathophysiology of water homeostasis, ECF volume strongly modulates the 
relationship between circulating osmolality and AVP release so that 
hypovolemia reduces the osmotic threshold and increases the slope of the 
response curve to osmolality; hypervolemia has the opposite effect, 
increasing the osmotic threshold and reducing the slope of the response 
curve. Notably, AVP has a half-life in the circulation of only 10-20 min; 
thus, changes in extracellular fluid volume and/or circulating osmolality can 
affect water homeostasis rapidly. In addition to volume status, a number of 
nonosmotic stimuli have potent activating effects on osmosensitive neurons 
and AVP release, including nausea, intracerebral angiotensin II, serotonin, 
and multiple drug. 
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The excretion or retention of electrolyte-free water by the kidney is 
modulated by circulating AVP. AVP acts on renal V2-type receptors in the 
thick ascending limb of Henle and principal cells of the collecting duct 
(CD), increasing cyclic adenosine monophosphate (AMP) and activating 
protein kinase A (PKA)-dependent phosphorylation of multiple transport 
proteins. The AVP- and PKA-dependent activation of Na+-Cl- and K+ 
transport by the thick ascending limb of the loop of Henle (TALH) is a key 
participant in the counter-current mechanism. The countercurrent 
mechanism ultimately increases the interstitial osmolality in the inner 
medulla of the kidney, driving water absorption across the renal collecting 
duct. However, water, salt, and solute transport by both proximal and distal 
nephron segments participates in the renal concentrating mechanism. Water 
transport across apical and basolateral aquaporin-1 water channels in the 
descending thin limb of the loop of Henle is thus involved, as is passive 
Euvolemic 
260 
Hypervolemic 
310                               270                            280                               290                               300  
Plasma osmolality (mOsm/Kg) 
Circulating levels of vasopressin (AVP) in response to changes in osmolality 
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absorption of Na+-Cl- by the thin ascending limb, via apical and basolateral 
CLC-K1 chloride channels and paracellular Na+ transport. Renal urea 
transport in turn plays important roles in the generation of the medullary 
osmotic gradient and the ability to excrete solute-free water under 
conditions of both high and low protein intake. 
AVP-induced, PKA-dependent phosphorylation of the aquaporin-2 
water channel in principal cells stimulates the insertion of active water 
channels into the lumen of the collecting duct, resulting in to excrete 
hypertonic, concentrated urine (osmolality of up the 1200 mosmol/kg). In 
the absence of circulating AVP, insertion of aquaporin-2 channels and 
water absorption across the collection duct are essentially abolished, 
resulting in secretion of a hypotonic dilute urine (osmolality as low as 30-
50 mosmol/kg). Abnormalities in this final common pathway are involved 
in most disorders water homeostasis, e.g., a reduced or absent insertion of 
action aquaporin-2 water channels into the membrane of principal cells in 
diabetes insipidus 
 
MAINTENANCE OF ARTERIAL CIRCULATORY INTEGRITY 
Sodium is actively pumped out of cells by the Na+, K+-ATPase 
membrane pump. In consequence, 85-90% of body Na+ is extracellular and 
the extracellular fluid volume (ECFV) is a function of total body Na+ 
content. Arterial perfusion and circulatory integrity  in turn, is determined 
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by renal Na+ retention or excretion, in addition to the modulation of 
systemic arterial resistance. Within the Kidney  Na+ is filtered by the 
glomeruli and then sequentially reabsorption by the renal tubules. The Na+ 
cation typically is reabsorbed with the chloride anion (CI-); thus, chloride 
homeostasis also affects  ECFV. On a quantitative level, at a glomerular 
filtration rate (GFR of 180 L/d and serum Na+ of 140 mEq/L, the kidney 
filters some 25,200 mmol/d of Na+-. This is equivalent to l.5 kg of salt, 
which would occupy roughly 10 times the extracellular space; 99.6% of 
Lumen filtered Na+-Cl- must be reabsorbed to excrete 100 mM per day. 
Minute changes in renal Na+-Cl- excretion will thus have significant effects 
on the ECFV, leading to edema syndromes or hypovolemia. 
 
Approximately two-thirds of filtered Na+-Cl- is reabsorbed in the 
renal proximal tubule via both paracellular and transcellular mechanisms. 
The TALH subsequently reabsorbs another 25-30. of filtered Na+-Cl- via 
the apical, furosemide-sensitive Na+-K+-2cl cotransporter. The adjacent 
aldosterone-sensitive distal nephron which encompasses the distal 
convoluted tubule (DCT), connecting tubule (CNT), and collecting duct, 
accomplishes the "fine-tuning of renal Na+- Cl- excretion. The thiazide-
sensitive  Na+ co transporter (NCC) reabsorbs 5-10% of filtered Na+-Cl- in 
the DCT. Principal cells in the CNT and CD reabsorb Na+ via, electrogenic  
amiloride-sensitive epithelial Na+ channels (ENaC); CI" ions are 
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reabsorbed primarily by adjacent intercalated cells via apical: CI- exchange 
(Cl'-OH" and Cl-HCO3- exchange, mediated by  SLC26A4 anion 
exchanger). 
 
Renal tubular reabsorption of filtered Na+-Cl- is regulated by 
multiple circulating and paracrine hormones in addition to activity of renal 
nerves. Angiotensin II activates proximal Na+Cl- reabsorption, as do 
adrenergic receptors under the influence of renal sympathetic innervations; 
locally generated dopamine, in contrast has a natriuretic effect. Aldosterone 
primarily activates Na+- its reabsorption within the aldosterone-sensitive 
distal nephron. in particular, aldosterone activates the ENaC channel in 
principal cells, inducing Na+ absorption and promoting K+ excretion. 
 
Circulatory integrity is critical for the perfusion and function of vital 
organs. Underfilling of the arterial circulation is sensed by ventricular and 
vascular pressure receptors, resulting in a neuro humoral activation 
(increased sympathetic tone, activation of the renin–angiotensin - 
aldosterone axis, and increased circulating AVP that synergistically 
increases renal Na+-Cl- reabsorption,  causes resistance, and renal water 
reabsorption. This occurs in the context of decreased cardiac output, as 
occurs in hypovolemic states, low output cardiac failure, decreased oncotic 
pressure, and/or increased capillary permeability. Alternatively, excessive 
arterial vasodilation results in relative arterial underfilling, leading to 
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neurohumoral activation in the defense of tissue perfusion. These 
physiological responses play important roles in many of the disorders.  In 
particular, it is important to appreciate that AVP functions in the defence of 
circulatory integrity; in during vasoconstriction, increasing sympathetic 
nervous system Tone, increasing renal retention of both water and Na+, Cl 
concomitant activation of V2 receptors in the kindey can result in renal 
water retention and Hyponatremia. 
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HYPONATREMIA 
 
           Hyponatremia is defined as serum sodium lower than 135mmol/litre, 
which is a common condition in hospital settings and is increasingly 
recognized in outpatients. Hyponatremia can be asymptomatic, although 
careful neurological evaluation has detected subtle abnormalities in patients 
with chronic hyponatremia and serum sodium as high as 132 mmol/litre. At 
the other end of the spectrum, presentation with hyponatremic 
encephalopathy (central nervous system symptoms secondary to cerebral 
edema) is a medical emergency that must be diagnosed promptly and 
treated quickly, or death or devastating neurological complications can 
result.17  
 The cause of hyponatremia can be divided into those in which water 
excretion is abnormal and those in which water excretion is normal but 
water ingestion is considerably increased.  
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Causes of Hyponatremia 
Hyponatremia with hypo osmolality  
Impaired water excretion (UOsm > 100mOsm/Kg and  usually < 300 mOsm 
/ Kg) 
 
Hypovolemic states  
 
 True volume depletion (by gastrointestinal, skin, or renal losses  
 Edematous states with reduced effective arterial blood volume  
- Congestive heart failure  
- Renal failure  
- Cirrhosis  
Diuretics (particularly thiazides)  
Pain  
Endocrine deficiencies (hypothyroidism and hypoadrenalism)  
Syndrome of inappropriate antidiuretic hormone secretion  
Cerebral salt wasting  
Reduced solute intake (tea-and-toast diet, beer drinkers hyponatremia) 
 
Normal Water excretion (Uosm > 100mOsm / Kg)  
 
Primary polydipsia  
Psychiatric disorders (particularly with phenothiazines)  
Hypothalamic disorders 
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Hyponatremia without hypoosmolality  
Normal Posm 
Pseudohyponatremia (hypertriglyceridemia, hyperproteinemia 
genitourinary tract irrigation)  
Increased Posm 
Hyperosmolar hyponatremia (hyperglycemia, mannitol infusion in renal 
failure)  
Azotemia (effective osmolaity is reduced)  
 
HYPOVOLEMIC HYPONATREMIA 
 A fall in effective perfusion pressure stimulates release of the three 
hypovolemic hormones: norepinephrine (which redirects blood flow away 
from the kidneys toward the brain and heart), angiotensin II (which 
enhances renal Na+ retention both directly and by promoting aldosterone 
release), and ADH (2). Hypovolemic hyponatremia can occur in states of 
dehydration or in edematous individuals with congestive heart failure 
(CHF) or advanced liver disease because each of these conditions is 
associated with a reduced effective arterial blood volume. As discussed 
previously, the resulting increase in the Uosm (e.g., to 600mOsm per kg) 
would limit renal water excretion on a 900 mOsm per day diet to 1.5L., 
assuming all of the ingested solute were excreted (900 mOsm per kg 600). 
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Solute excretion tends to be reduced in these settings, which are 
characterized by enhanced tubular salt reabsorption. In addition, most 
stimuli that activate angiotensin II release also stimulate thirst and lead to 
increased water ingestion, despite concurrent hypo osmolality. 
DIURETIC – INDUCED HYPONATREMIA2 
 The ability to excrete a dilute urine is impaired by diuretics, whether 
they act in the thick ascending limb of Henle (loop diuretics) or in the distal 
tubule (thiazide – type diuretics). Each class reduces salt transport out of 
the diluting segment, thus raising the minimum achievable Uosm from 50 
to approximately 250m Osm per kg, even in the absence of ADH. Reducing 
the minimum Uosm to this level, however, does not usually lead to 
hyponatremia because a large volume of urine can still be excreted by most 
patients. Almost all cases of diuretic –induced hyponatremia have been 
caused by thiazide-type other than loop diuretics. Loop diuretics which act 
in outer medulla, reduce the solute concentration in the renal medullary 
interstitium whereas ADH permits water reabsorption from the collecting 
tubule. By comparison, thiazide diuretics which act in cortex, impair 
diluting capacity but have a lesser effect on concentrating ability. For 
reasons that are not well understood, however most individuals with 
thiazide induced hyponatremia gain weight, indicating that hyponatremia is 
a part of increased water intake.  
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ADVANCED RENAL FAILURE  
 The normal glomerular filtration rate (GFR) is approximately 180L 
per day. As renal function decreases, the ability to excrete water also 
decreases. The limitation in water excretion occurs for two reasons: tubular 
dysfunction leads to an inability to dilute the urine maximally, even in the 
absence of ADH. The drop in GFR, particularly when severe, reduces daily 
solute excretion.  
ENDOCRINE DEFICIENCY  
 Hypothyroidism and hypocortisolism can impair water excretion. 
Both may reduce cardiac output or stroke volume, leading to increased 
ADH release the resulting fall in GFR adversely affects free water excretion 
diminishing delivery of filtrate to the diluting segments. Decreased delivery 
may be particularly important in patients with myxedema in whom 
hyponatremia may develop despite appropriate suppression of ADH 
release.  
 Another factor contributing to the hyponatremia of hypocortisolism 
is that corticotrophin-releasing factor promotes the release of 
adrenocorticotropic hormone (ACTH) and ADH, although the reason for 
the concomitant release of these hormones is not known. It is important to 
note that adrenocortical dysfunction (as in Addision’s disease) leads to 
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reduced cortisol and aldosterone levels, the latter predisposing to 
hyperkalemia. The presence of a low cortisol level alone, due to either 
pituitary or hypothalamic disease, or the abrupt withdrawal from prolonged 
exogenous corticosteroid administration may cause hyponatremia but 
should not alter potassium homeostais, because aldosterone release is 
normal.  
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE 
SECRETION:  
 The syndrome of inappropriate ADH secretion (SIADH) is 
characterized by the following. Plasma hypoosmolality, Uosm Above 100 
to 150 mOsm per kg; urinary Na+ concentration above 20mEq per L, 
reflecting normal renal perfusion; normal adrenal, renal, and thyroid 
function; and normal potassium and acid-base balance. SIADH may be 
caused by enhanced hypothalamic ADH secretion, ectopic hormone 
production (usually by cancer), potentiation of ADH effect (as with 
chlorpropamide), or administration of medications with ADH activity.  
 This disorder has been described in patients with hypovolemia, 
psychosis, and chronic malnutrition, and in normal pregnancy (in which the 
plasma Na+ concentration decreases by the second trimester from 140 to 
135mEq per L). ADH release is not suppressed until the Posm falls well 
below normal in this disorder.  
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 An increasingly common cause of hyponatremia is symptomatic 
human immunodeficiency virus (HIV) infection3. Although hyponatremia 
in HIV-infected patients may result from volume deficiency or adrenal 
insufficiency, may patients have SIADH. Pneumonia due to Pneumocystis 
jiroveci or other organisms, central nervous system infections, and 
malignant disease are most often responsible in this setting.  
CEREBRAL SALT WASTING4 
 Cerebral salt wasting is a rare disorder characterized by a low POsm, a 
UOsm above 100 to 150 mOsm per kg and a urine Na+ Concentration greater 
than 20mEq per L. Unlike SIADH, however, evidence of volume depletion 
(including low central filling pressures) is present. In affected individuals, 
therefore, the high urinary Na+ represents inappropriate salt wasting rather 
than a response to normal tissue perfusion (as in SIADH patients). 
REDUCED SOLUTE INTAKE 
 As noted, a reduction in salt and protein intake can lead to 
hypoosmolality if water intake exceeds output. Severely reduced solute 
intake, as occurs with a tea-and-toast diet, can cause hyponatremia even 
with normal degrees of water intake. “Beer drinkers hyponatremia” occurs 
for a similar reason: the limited amount of solute in beer relative to its water 
content may be inadequate to permit excretion of that water. In both 
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conditions, the UOsm less than 100 mOsm per kg). The absence of polyuria 
and the development of hyponatremia with normal or slightly above normal 
fluid intake distinguish these individuals from those with primary 
polydipsia 
HYPOOSMOLAR DISORDERS WITH NORMAL WATER 
EXCRETION 
 Psychiatric patients, particularly those with schizophrenia, often have 
abnormalities in water balance. Evaluation of psychotic patients has 
revealed that a variety of defects in water handling can occur that affect 
thirst, the release of ADH, and the renal response to ADH. Depending on 
the abnormality that is present, the patient may present with polydipsia and 
polyuria or hyponatremia 
 Hyponatremia has been reported in as many as 13% of marathon 
runners, and may occasionally be fatal. Although the exact mechanism has 
not been elucidated, risk factors for developing low serum sodium levels 
include weight gain during the race, female sex, racing time, and lower 
body mass indeed.5 
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PRIMARY POLYDIPSIA 
 Many chronically psychotic patients have moderate-to-marked 
increase in water intake. This may be manifested clinically by exaggerated 
weight gain during the day associated with a transient reduced in plasma 
sodium concentration. 
 Drug therapy may contribute to the increase in water intake to 
schizophrenic patients Many antipsychotic drugs induce the sensation of a 
dry mouth which enhance sensation of thirst. 
 Because people with normally functioning kidneys and regulation of 
ADH secretion are capable of excreting more than 10 to 15 L of urine per 
day, hyponatremia has developed even though the Uosm was appropriately 
dilute. More commonly however polydipsic patients manifesting 
hyponatremia have a concurrent abnormality in ADH release or response. 
Concurrent thiazide diuretic therapy for systemic hypertension can lead to 
the marked and symptomatic reduction in the plasma sodium concentration 
in these patients 
HYPONATREMIA WITHOUT HYPO OSMOLALITY 
 Hyponatremia may occur without plasma hypoosmolality. An 
increase in the plasma  concentration of proteins or lipids (primarily 
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triglyceride in lipemic plasma) can reduce the plasma Na+ concentration. 
Lipids and proteins displace water from a given volume of plasma but do 
not affect the Na+ concentration in the water phase of plasma. As a result, 
the measured Posm is normal in this condition, which is called 
pseudohyponatremia17. Because sodium concentration in the aqueous 
component of plasma is normal, this form of hyponatremia is not of 
pathophysiological consequence. 
 There are instances in which patients with plasma hyperosmolality 
may develop hyponatremia. This most commonly occurs with severe 
hyperglycemia or when mannitol is given to patients with renal failure 
resulting in osmotic shift of water from cells into ECF fluid diluting the 
plasma Na+ concentration. For every 100mg per dL of rise in blood sugar, 
plasma Na+ concentration falls by 1.6mEq per L.6  
SYMPTOMS OF HYPONATREMIA  
 A variety of symptoms may be found including lethargy, confusion, 
nausea, vomiting and in severe cases seizures and coma. Focal neurologic 
symptoms are uncommon.  
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PATHOPHYSIOLOGY OF CORTISOL PRODUCTION  
 
The adrenal cortex produces three classes of corticosteroid 
hormones: glucocorticoids (e.g., Cortisol), mineralocorticoids (e.g., 
aldosterone), and adrenal androgen precursors (e.g., dehydroepi-
androsterone, DHEA)   Glucocorticoids and mineralocorticoids act through 
specific nuclear receptors, regulating aspects of the physiologic stress 
response as well as blood pressure and electrolyte homeostasis. 
 
 Production of glucocorticoids and adrenal androgens is under  
control of the hypothalamic–pituitary–adrenal (HPA) axis, whereas 
mineralocorticoids are regulated by the renin angiotensin Aldosterone 
(RAA) system. 
 
 Glucorticoid synthesis is under inhibitory feedback control of 
hypothalamus and the pituitary hypothalamic release of corticotropin-
releasing hormone (CRH) occurs in response to endogenous or exogenous 
stress. CRH stimulates the cleavage of the 241-amino acid polypeptide pro 
opiomelanocortin (POMC) by pituitary-specific prohormone convertase, 
yielding adrenocorticotropic hormone (ACTH). ACTH is released by the 
corticotrope cells of the anterior pituitary and acts as the pivotal regulator 
of Cortisol synthesis, with additional short-term effects on 
mineralocorticoid and adrenal androgen synthesis. The release of CRH, and 
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subsequently ACTH, occurs in a pulsatile fashion that follows a circadian 
rhythm under the control of the hypothalamus, specifically its 
suprachiasmatic nucleus (SCN), with additional regulation by a complex 
network of cell-specific clock genes. Reflecting the pattern of ACTH 
secretion, adrenal Cortisol secretion exhibits a distinct circadian rhythm, 
with peak levels in the morning and low levels in the evening.8 
 
Cortisol is inactivated to cortisone by the microsomal enzyme                    
11-hydroxysteroid dehydrogenase type 2 (11-HSD2) mainly in the 
kidney, but also in the colon, salivary glands, and other target tissues. 
Cortisol and aldosterone bind the mineralocorticoid receptor (MR) with 
equal affinity; however, Cortisol circulates in the bloodstream at about a 
thousand fold higher concentration. Thus, only the rapid inactivation of 
Cortisol to cortisone by 11-HSD2 prevents MR activation by excess 
Cortisol, thereby acting as a tissue-specific modulator of the MR pathway. 
In addition to Cortisol and aldosterone, deoxycorticosterone (DOC) also 
exerts mineralocorticoid activity. DOC accumulation due to 11-
hydroxylase deficiency or due to tumor-related excess production can result 
in mineral corticoid excess.22 
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DIAGNOSTIC EVALUATION OF HYPONATREMIA 22 
Clinical assessment of hyponatremic patients should focus on the 
underlying cause; a detailed drug history is particularly crucial. A careful 
clinical assessment of volume status is obligatory for the classical 
diagnostic approach to hyponatremia. Hyponatremia is frequently 
multifactorial, particularly when severe; clinical evaluation should consider 
all the possible causes for excessive circulating AVP, including volume 
status, drugs, and the presence of nausea and/or pain. Radiologic imaging 
also may be appropriate to assess whether patients have a pulmonary or 
CNS cause for hyponatremia. A screening chest X-ray may fail to detect a 
small cell carcinoma of the lung; CT scanning of the thorax should be 
considered in patients at high risk for this tumor, e.g., patients with a 
history of smoking. 
 
Laboratory investigation should include a measurement of serum 
osmolality to exclude pseudohyponatremia, which is defined as the 
coexistence of hyponatremia with a normal or increased plasma tonicity. 
Most clinical laboratories measure plasma Na+ concentration by testing 
diluted samples with automated ion-sensitive electrodes, correcting for this 
dilution by assuming  that plasma is 93% water; this correction factor can 
be inaccurate in patients with pseudohyponatremia due to extreme 
hyperlipidemia and/ or hyperproteinemia, in whom serum lipid or protein 
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makes up a greater percentage of plasma volume. The measured osmolality 
also should be converted to the effective osmolality (tonicity) by 
subtracting the measured concentration of urea (divided by 2.8 if in mg/dL); 
patients with hyponatremia have an effective osmolality <275 mosmol/kg. 
 
Elevated BUN and creatinine in routine chemistries also can indicate 
renal dysfunction as a potential cause of hyponatremia, whereas 
hyperkalemia may suggest adrenal insufficiency or hypoaldosteronism. 
Serum glucose also should be measured; plasma Na+ concentration falls by 
-1.6 to 2.4 mM for every 100-mg/dL increase in glucose due to glucose-
induced water efflux from cells; this "true" hyponatremia resolves after 
correction of hyperglycemia. Measurement of serum uric acid also should 
be performed; whereas patients with SIADH-type physiology typically will 
be hypouricemic (serum uric acid <4 mg/dL), volume-depleted patients 
often will be hyperuricemic. In the appropriate clinical setting, thyroid, 
adrenal, and pituitary function should also be tested; hypothyroidism and 
secondary adrenal failure due to pituitary insufficiency are important causes 
of euvolemic hyponatremia, whereas primary adrenal failure causes 
hypovolemic hyponatremia. A cosyntropin stimulation test is necessary to 
assess for primary adrenal insufficiency. 
 Urine electrolytes and osmolality are crucial tests in the initial 
evaluation of hyponatremia. A urine Na+ concentration <20-30 mM is 
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consistent with hypovolemic hyponatremia in the clinical absence of a 
hypervolemic, Na+-avid syndrome such as CHF. In contrast, patients with 
SIADH typically excrete urine with a Na+ concentration that is >30 mM. 
However, there can be substantial overlap in urine Na+ concentration values 
in patients with SIADH and hypovolemic hyponatremia, particularly in the 
elderly; the ultimate "gold standard" for the diagnosis of hypovolemic 
hyponatremia is the demonstration that plasma Na+ concentration corrects 
after hydration with normal saline. Patients with thiazide-associated 
hyponatremia also may present with a higher than expected urine Na+ 
concentration and other findings suggestive of SIADH; one should defer 
making a diagnosis of SIADH in these patients until 1-2 weeks after 
discontinuation of the thiazide. A urine osmolality <100 mosmol/kg is 
suggestive of polydipsia; urine osmolality >400 mosmol/kg indicates that 
AVP excess is playing a more dominant role, whereas intermediate values 
are more consistent with multifactorial pathophysiology (e.g., AVP excess 
with a significant component of polydipsia). Patients with hyponatremia 
due to decreased solute intake (beer potomania) typically have urine Na+ 
concentration <20mM and urine osmolality in the range of < 100 to the low 
200's. Finally, the measurement of urine K+ concentration is required to 
calculate the urine:plasma electrolyte ratio, which is useful to predict the 
response to fluid restriction. 
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ALGORITHM TO DIAGNOSE HYPONATREMIA 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Plasma osmolality 
High > 290mOsm/ kg Normal275 -290mOsm/kg 
Hyperglycemia 
Mannitol 
Hyperproteinemia  
Hyperlipidemia  
Bladder irrigation  
Low < 275mOsm/kg 
Urine Osmolality  
>100mOsm/ kg <100mOsm/ kg 
ECF Volume 
Primary Polydipsia  
Beer potomania  
Post TURP 
Euvolemic Hypovolemic Hypervolemic 
Heart failure 
Hepatic cirrhosis 
Nephrotic syndrome 
SIADH 
Exclude hypothyroidsm  
Urine Na Concentration
<10m mol/L >20m mol/L 
Extra-renal Na+ loss 
diuretic use  
vomiting 
Na+ wasting nephropathy 
Hypo-aldosteronism  
Diuretic  
Bicarbonaturia  
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AIM OF THE STUDY 
 
1. To evaluate the common causes of Hyponatremia in patients 
admitted to Government Rajaji Hospital Madurai.  
 
2. To findout if there is any correlation between serum cortisol values 
and low serum sodium values in our patients.  
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MATERIALS AND METHODS 
 
Definition  :   Hyponatremia is defined as serum sodium concentration 
of less than 130mEq/L16  Normal Cortisol Levels – 4.3 – 
22.0g/dl : (7 – 9 AM)18 
Study Area  :   Madurai Medical College and Government Rajaji 
Hospital Madurai which is one of the largest Hospitals 
in Tamilnadu. 
Study Design  :   Observational Study 
Study Period  :   November 2010 to November 2011 
Sample Size  : 50 inpatients 
 
Study Population 
 All the Inpatients both male and female who were admitted for 
various ailments whose biochemical values showed serum sodium to be less 
than 130mEq/l.(values confirmed with repeat sample) 
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Inclusion Criteria  
i) All inpatients who were admitted both in General wards & ICU 
irrespective of their age / sex who showed Hyponatremia 
(confirmed with two consecutive low values)  
Exclusion Criteria  
i) Patients who were on treatment with steroids for various diseases 
were excluded.  
ii) Female Patients who were pregnant were excluded. 
Study Method  
 Basal cortisol levels were estimated inpatients with hyponatremia 
with blood samples drawn on the next day morning between 7.00 AM – 
9.00 AM and results were Analysed. Other biochemical  parameters like 
Blood Sugar, Urea, Serum Creatinine, Serum potassium were estimated. 
Serum osmolality was calculated with the formula given below and patients 
were classified.  
Serum osmolality = 2 x serum Na+ + Blood Sugar (in mg/dl)      +   Blood Urea (mg/dl)
                  18              6  
  
 Other clinical data like age/sex, pulse rate, Blood Pressure, Edema, 
Volume Status, Urine Output were also estimated.  
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Lab Methods  
 
 The Biochemistry lab is a standardized Laboratory. The methods 
used for estimation are 
1. Serum Sodium   - HILITE / TRANSMINASE 
2. Serum Potassium  - I.S.Electrode  
(Ionselective Electrophoresis)  
3. Urea    - Glutaraldehyde LDH 
4. Creatinine   - Jaffe Kinetic   
5. Sugar    - (Glucose Per Oxidase) 
6. Serum Cortisol   - Chemiluminescence  
 
 
STATISTICAL TOOLS 
 The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2010) 
developed by Centre for Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, standard 
deviations, chi square and  'p'  values were calculated. Kruskul Wallis chi-
square  test was used to test the significance of difference between 
quantitative variables and Yate’s chi square test for qualitative variables. A 
'p' value less than 0.05 is taken to denote significant relationship. 
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RESULTS AND ANALYSIS 
 
 
 
FIGURE 1
AGE DISTRIBUTION
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TABLE 2
AGE AND SEVERITY WISE DISTRIBUTION OF HYPONATREMIA
AGE NUMBER MILD(126‐
130meq/L)
MODERATE(
120‐
125meq/L)
SEVERE(<120m
eq/L)
PERCENTA
GE
12‐25yrs 4 2 2 ‐ 8
26‐45yrs 14 7 4 3 28
46‐64yrs 17 7 5 5 34
>=65yrs 15 7 7 1 30
TOTAL 50 23(46%) 18(36%) 9(18%) 100
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FIGURE 2:
AGE & CORTISOL LEVELS
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FIGURE 3:
SEX DISTRIBUTION
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FIGURE 4:
SEX & CORTISOL LEVEL
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FIGURE 5:
OSMOLAR DISTRIBUTION
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FIGURE 6:
VOLUME STATUS
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FIGURE 7:
CORTISOL LEVELS
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FIGURE 8:
CORTISOL LEVEL & 
BLOOD SUGAR/ UREA / SODIUM
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FIGURE 9:
PAIN AND SERUM CORTISOL
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FIGURE 10:
AGE AND SERUM CORTISOL
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DISCUSSION 
 The present study included patients with serum sodium less than 
130mEq/L16. In these, there were 27 males and 23 females in the ratio of 
1.17:1. In our hospital, usually there are more number of male patients 
admitted than female patients. Hence this slight increase in male patients 
was not very significant.(TABLE  4) 
         In the present study hyponatremia is commonly seen in patients more 
than 45 years. Similar results were observed by Hochmann13 and Vurgese16  
in their studies. Mean age of the patients of the present study was 52.5 
years(TABLE 1). 
       This is similar to Vurgese16 study, which showed a mean age of 57.05 
years and Anderson25 study, which showed a mean age of 58 years. The 
commonest age group was 45-64 years, and the least affected was 13-25 
years(TABLE 2); which also showed similar results with Vurgese16 study. 
     Based on the serum sodium concentration, the hyponatremia was 
classified into mild, moderate and severe, with serum sodium levels of 126-
130mEq/L, 120-125mEq/L and <120 mEq/L respectively16. In the study by 
Hochman et al13  , there were 39% of patients with mild hyponatremia and 
the rest of the 61% had moderate to severe hyponatremia. In the study by 
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Vurgese13, 33% of the patients had mild hyponatremia and 67% of the 
patients had moderate to severe hyponatremia. 
 In our study 46% of patients had mild hyponatremia where as 54% of 
patients had moderate to severe hyponatremia(TABLE 2) which is slightly 
in variance with the above studies. No significance could be attached to 
difference in this incidence. 
 The hydration status of the patients were classified based on the 
clinical examination. They were divided into euvolemic, hypovolemic and 
hypervolemic states. In the present study 23 patients were hypervolemic; 11 
patients were hypovolemic and 16 were euvolemic. Comparative results are 
shown in the below table 
TYPE ANDERSON % PRESENT  STUDY % 
EUVOLEMIA 34 32 
HYPERVOLEMIA 31 46 
HYPOVOLEMIA 35 22 
  
       This correlated with other studies, but our study showed a slight 
increase in the patients with hypervolemia. This is in slight variance with 
other studies. This may probably be due to increased number of patients 
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with chronic kidney disease with volume overload status(TABLE 14) ;in 
our study similar results were obtained in patients with euvolemia status. 
         On further evaluation of the causes of hyponatremia in our patients, 
our study showed similar results to the studies done by Vurgese et al16  
        Comparative analysis of common causes in our study with Vurgese et 
al16 is shown in the table below, 
OUR STUDY VURGESE et al16 
Chronic kidney disease 13 
(26%) 
Renal failure (acute and 
chronic) 13 (19.6%) 
Respiratory causes-10 (20%) 
       Ca lung-2 
       Pneumonia-4 
      COPD-2 
      Pulmonary tuberculosis-2 
SIADH(23%) due to 
      Pneumonia-13 
     Drugs-2 
     COPD-3 
     Bronchiectasis -3 
     Bronchogenic Carcinoma-3
     HIV-1 
Congestive cardiac failure-
5(10%) 
Congestive cardiac failure-
12(18%) 
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Acute gastro enteritis-4(8%) Acute gastro enteritis-2(3%) 
Chronic liver disease-2(4%) Chronic liver disease-4(6%) 
Diabetes mellitus-2(4%) Diabetes mellitus-4(6%) 
 
           Due to limited resources availability the other investigations like 
urine osmolarity and urine sodium levels could not be estimated. 
           Our present study showed hypo osmolarity in 39 of 50 patients. And 
normal osmolarity in 7 out of 50 patients, which is similar to the results 
shown by studies of Devita et al15. the comparative results are shown in the 
table below 
 OUR STUDY DEVITA MV et al 
HYPOOSMOLAR 78% 83% 
NORMOOSMOLAR 14% 17% 
HYPEROSMOLAR 8% - 
 
        Many of the causes of hyponatremia have multifactorial 
pathophysiology. patients with congestive cardiac failure have 
hypervolemic hyponatremia due to salt and water retention. They also have 
hyponatremia due to low salt diet and diuretic therapy. Similarly patients 
  56
with diabetes mellitus have hyponatremia possibly due to associated renal 
failure, SIADH, due to drug therapy and also some amount of pseudo 
hyponatremia due to excess blood sugar causing hyperosmolar 
hyponatremia. In cerebrovascular accidents22, the hyponatremia is usually 
due to SIADH and mannitol therapy. 
       Regarding the correlation of serum basal cortisol levels with 
hyponatremia- only 17 of the 50 patients with hyponatremia showed 
increase in basal cortisol levels(TABLE 6) 
        There is no significant association found with serum cortisol and low 
serum sodium values in our patients. This is similar to the results obtained 
by P.A.Mason et al11  who showed that cortisol levels were unaffected by 
sodium depletion. Similar results were also obtained by F.A.O.MENDEL 
SOHN et al12 who concluded that plasma cortisol was unaffected by sodium 
deprivation. Studies of R.Fraser et al11 also showed similar results. Though 
serum cortisol has both glucocorticoid and mineralocorticoid activity, there 
is no significant  sodium retention seen in our study. This may be probably 
due to the enzyme 11 beta hydroxy steroid dehydrogenase 2(11βHSD2), 
which selectively inactivates cortisol to cortisone, prevents 
mineralocorticoid receptor activation by cortisol. Aldosterone and arginine 
vasopressin seems to be more concerned with sodium and water 
homeostasis. 
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       The average values of serum basal cortisol was 18±1.6µg/100ml in 
studies by F.A.O.Mendel  sohn et al12. Our study showed an average serum 
cortisol levels of 17.54µg/100ml (TABLE 6) which is similar to the above 
said study. 
      The average age of the patients where serum cortisol was found to be 
increased was 61.9years in our study(TABLE 3/ TABLE 15) . Similar 
results were seen in studies by F.A.O.Mendel sohn et al12 which showed an 
average age of 56years. Hence our study correlated well with other studies.  
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CONCLUSION 
1. Our study shows chronic kidney disease with volume overload as the 
most common cause of hyponatremia.  
2. Other common causes include respiratory causes, fever, congestive 
cardiac failure, acute gastro enteritis and CNS tumours.  
3. Raised cortisol levels do not seem to correlate with low sodium 
values. 
4. No significant association is seen between pulse rate, blood pressure 
and increase in cortisol levels.  
5. Older patients seem to have higher levels of basal cortisol during the 
illness.  
6. Mean serum sodium value was found to be 123 mEq/L in our study 
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PROFORMA  
 
 
Name  :   
Age / Sex  :  IP No. 
Address  :    
 
 
Vitals  :  PR  :  BP :  RR  :  
 
    Conscious / Unconscious 
  CNS 
    Infections / Metabolic 
 
 
Vomiting  :  CCF  : 
Diarrhoea  :  CKD  : 
Pain  :  CLD  : 
Edema  :  Nephrotic Syndrome 
Anemia  :  Lung infections 
Thyroid swelling  :  Tumours  
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Drug Intake:  
 
  Carbamazepine 
  Phenothiazine 
  Tricyclic antidepressant 
  SSRI 
  Cyclophophamide 
  Vincristine 
 
Diuretic 
Mannitol 
IV fluids  
 
 
 
AGE SEX PR BP DIAR VOMIT PAIN EDEMA ANEMIA THYROID DRUGS DIAG IVF DIURETIC BS UREA Cr Na K CORTISOL URINE
53 m 100 100/70 1 pneumonia 117 37 0.9 109 2.2 8.68 800 231
42 M 80 90/60 1 AGE 1 60 33 1.5 126 2.9 12.6 1000 261
40 F 86 140/80 1 1 FEVER 1 108 21 0.9 127 3.5 8 800 263
75 M 86 80/60 1 1 1 CKD 1 83 198 3.2 123 3.2 25.9 i 300 286
75 M 120 140/90 1 1 CKD 1 94 32 2.4 120 3.9 18 i 600 250
65 M 80 200/100 1 CVA 1 72 24 0.8 128 4.1 17 i 1000 264
43 M 86 100/70 1 CKD 1 89 18 0.9 128 3.9 6.6 600 264
40 M 137 100/70 1 1 1 CCF 1 101 75 1.2 127 4.7 34.3 i 600 273
60 M 72 100/70 1 1 CCF 1 73 44 1.2 129 3.4 16.5 800 270
55 M 90 110/70 1 1 CKD 1 117 230 8.2 125 5.8 28.5 i 100 297
40 M 80 180/100 1 1 1 CKD 1 80 209 8.8 127 4.8 8.13 800 296
58 M 82 130/70 1 1 CCF 112 20 0.7 128 4.2 6.9 1000 265
76 M 82 150/90 1 pneumonia 127 35 1 127 4.6 45.2 i 800 265
70 F 68 170/100 1 1 1 1 1 114 42 0.9 120 3.6 16 800 254
48 F 86 150/100 1 1 1 SLE 1 112 85 4.2 112 3.6 10 400 245
65 M 82 140/90 1 1 1 AGE 93 31 1.3 116 6.1 11.6 600 242
80 F 80 140/80 1 1 1 1 1 229 34 1 122 3.4 23.5 i 800 263
32 M 98 110/80 1 FEVER 65 16 0.9 120 3.9 19.4 1200 246
55 F 98 90/70 1 1 AGE 98 22 0.8 123 3.3 9.9 600 255
46 F 86 100/70 FEVER 91 15 0.7 129 3.5 8.9 1000 266
49 F 76 130/80 1 FEVER/DM 220 32 1 124 3.7 16 600 266
23 F 78 100/70 1 1 136 17 0.7 120 3.5 0.8 600 250
77 M 86 160/80 1 Ca Lung 126 34 0.8 128 2.9 28.9 i 650 269
52 M 78 100/70 1 1 CLD 1 64 64 2.5 123 3.7 20 i 900 261
20 M 100 90/70 1 1 1 CLD 68 48 0.6 125 3.7 1.09 150 262
85 F 88 130/80 1 1 1 CKD 108 156 9.3 125 3.7 24.3 i 1200 283
65 F 76 130/70 LRTI 206 43 0.9 121 3.7 12.3 1000 242
58 F 84 210/110 1 1 CKD 60 101 3.4 129 6.9 12.8 600 279
35 F 90 140/100 1 CKD 81 112 3.4 114 4.2 21.2 i 800 252
39 M 96 120/80 1 1 PTB 83 25 0.7 121 3.6 16 700 251
45 M 76 190/100 1 1 1 1 CCF/CKD 1 193 253 17.6 123 4.9 63 i 700 301
OSMOLAL
ITY
CNS tumour
CNS tumour
Aplastic Ane
58 F 96 120/90 LRTI 110 24 1 125 3.8 16.9 i 600 260
70 F 84 120/80 1 1 Ca Lung 201 19 0.9 125 3.3 15 800 264
31 M 80 140/70 1 1 CKD 128 73 2.3 125 5.6 15 600 270
70 M 100 190/90 COPD/SHT 68 58 1.3 126 4 25.4 i 1200 266
53 F 84 180/100 1 1 1 CKD 114 130 4.5 127 6 10.4 800 283
65 M 78 150/90 CVA 1 142 138 1.9 126 4.3 20.5 550 284
60 M 120 60/40 1 pneumonia 244 143 1.6 118 4.8 56 i 900 275
52 M 86 100/70 1 1 DM/UTI 354 34 1.1 115 3.3 23 i 600 256
70 M 125 110/70 1 COPD 182 59 1.9 127 4.4 9.25 800 275
52 M 110 90/60 1 1 1 PTB 98 37 0.8 118 3.6 23 i 800 248
21 F 80 130/90 1 1 OPC 67 16 0.6 126 3.1 8.5 1300 259
40 F 102 100/70 1 1 AGE 108 25 1.2 108 3.3 9 600 226
42 F 104 160/100 1 CCF 1 62 19 0.9 128 3.7 8.4 1000 262
55 M 102 100/70 1 1 CBZ SEIZURES/DM 410 144 1.5 126 4.6 5.6 300 300
30 F 96 100/70 FEVER 108 35 1.2 128 3.5 16.2 1200 268
37 F 88 160/120 1 1 1 SLE/CKD 1 98 56 2 108 5 11.4 600 231
70 F 90 100/70 1 DCM 90 34 1.1 126 3.8 18.2 900 263
60 F 86 150/100 1 1 1 CKD 88 66 4 128 5.1 19.5 700 272
25 F 90 100/70 1 FEVER 86 20 0.8 128 3.6 13.7 1200 264
